EINDHOVEN, Netherlands, Sept. 13, 2021 /PRNewswire/ -- STENTiT, a medical device company bringing a novel class of regenerative endovascular implants for treatment of cardiovascular diseases, today announced the appointment of its Medical Advisory Board, chaired by Prof. Patrick Serruys...
from PR Newswire: https://ift.tt/3lA2bdF
No comments:
Post a Comment